Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/26/2019
SMEI: Top Chemical Drug Products in Urban Chinese Retail Pharmacies 20...
8/26/2019
IQVIA: Overall Chinese Pharma Market Growth Slowed to 4.5% in 2018
8/26/2019
Review of Chinese Drug Evaluation and Registration in 2018
8/26/2019
Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
8/23/2019
Chi-Med Initiates Phase I Trial of HMPL-523 for Immune Thrombocytopeni...
8/23/2019
111 Signs Strategic Partnership with TK.CN to Empower PBM and Insuranc...
8/23/2019
China to Step Up Crackdown on Drug Monopoly to Keep Prices and Supply ...
8/21/2019
China's Biopharma Strategy: Challenge or Complement to U.S. Industry C...
8/21/2019
Innovent Enters a Licensing Agreement with Lilly to Develop & ...
8/21/2019
Alligator Bio and Biotheus Enter Antibody Agreement for Greater China
8/21/2019
USFDA Grants Priority Review to BeiGene's Zanubrutinib in Patients wit...
8/21/2019
CMAB and Kintor Announce a New Partnership to Develop and Manufacture ...
8/20/2019
China's Central Government Introduces Major Policy Incentives and Rest...
8/20/2019
Chronic and Aging-related Diseases Cost Over Half of Chinese BMI Spend...
8/19/2019
NMPA Issues the Administrative Measures for Drug Quality Sampling Insp...
8/19/2019
CitiResearch - China at Inflection Point: Big Opportunity for MNCs, Do...
8/19/2019
Sanofi Gains Chinese IND Approval for RNAi Therapy Fitusiran Injection
8/16/2019
Regulator Penalizes 22 at Kangmei for $12.6 Billion of Overstatements
8/16/2019
China to Enhance Common Medicine Supply through New Measures
8/16/2019
Sun Pharma Expands Partnership with CMS for Generic Drugs in Mainland ...
8/16/2019
How to Use China's 2019 Negative Lists
8/14/2019
China Has Become A CEO-Level Priority for MNC Cos: Trend and Implicati...
8/14/2019
Sinohealth Projects Lower Chinese Pharmaceutical Market Growth in 2019
8/14/2019
CSL Maintains Positive China Business Outlook Despite Short Term Headw...
8/13/2019
IQVIA Market Prognosis Projects 4.8% CAGR for Chinese Pharmaceutical M...
8/13/2019
NHC Releases List of Trial Site Cities of Urban Medical Consortium Exp...
8/13/2019
State Council Introduces New Policy with Healthcare Reform Provisions
8/12/2019
CASI Pharmaceuticals Announces Launch of EVOMELA (melphalan for inject...
8/12/2019
Nanjing King-Friend to Invest US$95M in Injectable Specialist Meitheal...
8/12/2019
SMEI: Review of Chinese Terminal Drug Markets in 2010-H1/2019
Page:
134
/
357
Total number of articles:
10695
:
[First]
[<<]
[132]
[133]
[134]
[135]
[136]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit